New agreement for AFT Pharmaceuticals with Leading European Pharma
AFT Pharmaceuticals (AFT’) has executed an alliance agreement with privately-owned pharmaceutical company, Angelini, to license the product line of its patented combination cold and flu product, Maxiclear, to a number of countries predominantly in Europe: Italy, San Marino, Vatican City, Spain, Portugal, Greece, Bulgaria, Croatia, Czech Republic, Slovakia, Austria, Romania, Poland, Hungary, Turkey and Russia.
Maxigesic Now Licensed in 109 Countries
New agreement for AFT Pharmaceuticals means Maxigesic is now licensed in 109 countries
New Zealand’s world-first combination analgesic
AFT Pharmaceuticals has released Maxigesic®, a new analgesic tablet which for the first time in NZ combines Paracetamol and the anti-inflammatory Ibuprofen to provide superior pain relief to patients than either agent on its own.